Literature DB >> 10102343

Cell-specific expression of the diphtheria toxin A-chain coding sequence under the control of the upstream region of the human alpha-fetoprotein gene.

Y Murayama1, T Tadakuma, M Kunitomi, K Kumai, K Tsutsui, T Yasuda, M Kitajima.   

Abstract

BACKGROUND AND OBJECTIVES: Development of the system to express a suicide gene selectively in tumor cells is essential for gene therapy. We constructed a plasmid containing the diphtheria toxin A (DTA) fragment linked to human alpha-fetoprotein (AFP) promoter and enhancer, and tested whether it can exert its cytocidal effect selectively on AFP-producing cells.
METHODS: The chloramphenical acetyltransferase (CAT) reporter gene or DTA gene was linked to the 5' upstream region of the AFP gene. The plasmids were transfected into AFP-producing or non-producing cells by the lipopolyamine-coated DNA method. Expression of CAT activity and effects on cell growth of transfected cells were assessed.
RESULTS: When the AFP-producing cells HuH-7 or HepG2 were cotransfected with CAT reporter plasmid and pAF5.1DTA plasmid, the CAT activity was greatly suppressed. In contrast, cotransfection with pAF5.1DTA-R, the inversely inserted DTA gene, did not inhibit CAT activity. Furthermore, cell growth of HuH-7 cells transfected with pAF5.1DTA plasmid was significantly inhibited compared with HuH-7 cells transfected with DTA-R plasmid.
CONCLUSIONS: Our results indicate that selective killing of AFP-producing cells will be attained by introducing the DTA gene linked to the promoter and enhancer region of AFP.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10102343     DOI: 10.1002/(sici)1096-9098(199903)70:3<145::aid-jso1>3.0.co;2-o

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  7 in total

Review 1.  The potential for gene therapy in pancreatic cancer.

Authors:  M J Humphreys; W Greenhalf; J P Neoptolemos; P Ghaneh
Journal:  Int J Pancreatol       Date:  1999-08

2.  Treatment of ovarian cancer ascites by intra-peritoneal injection of diphtheria toxin A chain-H19 vector: a case report.

Authors:  Aya Mizrahi; Abraham Czerniak; Patricia Ohana; Smadar Amiur; Jennifer Gallula; Imad Matouk; Rasha Abu-Lail; Tatiana Birman; Abraham Hochberg; Tally Levy
Journal:  J Med Case Rep       Date:  2010-07-27

3.  PG13 packaging cells produce recombinant retroviruses carrying a diphtheria toxin mutant which kills cancer cells.

Authors:  Jian Qiao; Manuel Caruso
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

4.  Construction of a targeting adenoviral vector carrying AFP promoter for expressing EGFP gene in AFP-producing hepatocarcinoma cell.

Authors:  Yu-Jun Shi; Jian-Ping Gong; Chang-An Liu; Xu-Hong Li; Ying Mei; Can Mi; Yan-Ying Huo
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

Review 5.  Toxin-based therapeutic approaches.

Authors:  Assaf Shapira; Itai Benhar
Journal:  Toxins (Basel)       Date:  2010-10-28       Impact factor: 4.546

Review 6.  Targeted Diphtheria Toxin-Based Therapy: A Review Article.

Authors:  Fatemeh Shafiee; Marc G Aucoin; Ali Jahanian-Najafabadi
Journal:  Front Microbiol       Date:  2019-10-18       Impact factor: 5.640

7.  Transcriptional Targeting in Cancer Gene Therapy.

Authors:  Tracy Robson; David G. Hirst
Journal:  J Biomed Biotechnol       Date:  2003
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.